Institute of Pathogen Biology, Chinese Academy of Medical Sciences

Chine

 
Quantité totale PI 12
Rang # Quantité totale PI 128 033
Note d'activité PI 1,3/5.0    4
Rang # Activité PI 240 617

Brevets

Marques

1 0
1 0
10 0
0
 
Dernier brevet 2024 - Membrane fusion inhibitor for in...
Premier brevet 2008 - A newly identified human rhinovi...

Derniers inventions, produits et services

2023 Invention Membrane fusion inhibitor for inhibiting aids virus and drug-resistant strain thereof, and pharma...
2022 Invention Broad-spectrum coronavirus membrane fusion inhibitor and pharmaceutical use thereof. The present ...
2020 Invention Schistosoma haematobium recombinant fusion protein shsap and application thereof in immunodiagnos...
2019 Invention Application of cas13a in antagonizing viruses. Provided is an application of Cas13a in antagonizi...
2017 Invention Lipopeptide for potently inhibiting hiv, derivative thereof, pharmaceutical composition thereof a...
Invention Potent hiv inhibiting lipopeptide, derivative thereof, pharmaceutical composition thereof and use...
Invention Hiv inhibiting broad-spectrum lipopeptide, derivatives thereof, pharmaceutical compositions there...
2012 Invention Method for detecting human papillomavirus genotypes with high accuracy. The present invention pro...
Invention Short polypeptide inhibiting hiv and pharmacal use. Disclosed in the present invention are a shor...
2009 Invention Newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs. The charact...
Invention A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs. The chara...
2008 Invention A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs. The prese...